Literature DB >> 17592696

Osteochondral lesions of the talus: results of repeat arthroscopic debridement.

Nicholas Savva1, Majid Jabur, Mark Davies, Terry Saxby.   

Abstract

BACKGROUND: Repeat arthroscopic debridement of osteochondral lesions of the talus has a poor reputation despite a paucity of evidence in the literature.
METHODS: We reviewed all patients who had repeat arthroscopic debridement of an osteochondral lesion performed by the senior author. They were scored using the American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Scale, and lesions were graded using the system described by Berndt and Harty.
RESULTS: Between 1993 and 2002, 808 consecutive ankle arthroscopies were performed by the senior author, of which 215 were to treat osteochondral lesions of the talus. Of these, 12 had repeat arthroscopies because of unresolved symptoms. AOFAS scores improved from a mean of 34.8 prior to arthroscopy to 80.5 after repeat arthroscopy at a mean followup of 5.9 years (18 months to 11 years). Two patients returned to professional sports after the second procedure. Six patients returned to their preinjury levels of sporting activity and three returned to the same sports but played to a lesser standard or less frequently. One patient had already had a cartilage transplantation procedure.
CONCLUSIONS: This is the first series specifically assessing patients who have had repeat arthroscopic debridement of osteochondral lesions of the talus, using the same debridement technique by a single surgeon. Our results question the assumption that repeat arthroscopic debridement yields poor results. They also provide a baseline for the newer chondral and osteochondral transplantation techniques to compare to at the medium term.

Entities:  

Mesh:

Year:  2007        PMID: 17592696     DOI: 10.3113/FAI.2007.0669

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  8 in total

1.  Should Arthroscopic Bone Marrow Stimulation Be Used in the Management of Secondary Osteochondral Lesions of the Talus? A Systematic Review.

Authors:  Zaki Arshad; Aiman Aslam; Adil M Iqbal; Maneesh Bhatia
Journal:  Clin Orthop Relat Res       Date:  2022-02-07       Impact factor: 4.755

Review 2.  [Diagnosis and treatment of osteochondral lesions of the talus].

Authors:  M Merian; M Easley
Journal:  Orthopade       Date:  2008-03       Impact factor: 1.087

Review 3.  Current concepts: tissue engineering and regenerative medicine applications in the ankle joint.

Authors:  S I Correia; H Pereira; J Silva-Correia; C N Van Dijk; J Espregueira-Mendes; J M Oliveira; R L Reis
Journal:  J R Soc Interface       Date:  2013-12-18       Impact factor: 4.118

Review 4.  Diagnosis and treatment of osteochondral lesions of the ankle: current concepts.

Authors:  Marcelo Pires Prado; John G Kennedy; Fernando Raduan; Caio Nery
Journal:  Rev Bras Ortop       Date:  2016-08-17

Review 5.  No superior surgical treatment for secondary osteochondral defects of the talus.

Authors:  Kaj T A Lambers; Jari Dahmen; Mikel L Reilingh; Christiaan J A van Bergen; Sjoerd A S Stufkens; Gino M M J Kerkhoffs
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-07-07       Impact factor: 4.342

Review 6.  Return to Sports After Surgical Treatment of Osteochondral Defects of the Talus: A Systematic Review of 2347 Cases.

Authors:  Jason A H Steman; Jari Dahmen; Kaj T A Lambers; Gino M M J Kerkhoffs
Journal:  Orthop J Sports Med       Date:  2019-10-22

7.  Outcomes of Bone Marrow Stimulation for Secondary Osteochondral Lesions of the Talus Equal Outcomes for Primary Lesions.

Authors:  Quinten G H Rikken; Jari Dahmen; Mikel L Reilingh; Christiaan J A van Bergen; Sjoerd A S Stufkens; Gino M M J Kerkhoffs
Journal:  Cartilage       Date:  2021-06-24       Impact factor: 4.634

8.  Evidence-based Treatment of Failed Primary Osteochondral Lesions of the Talus: A Systematic Review on Clinical Outcomes of Bone Marrow Stimulation.

Authors:  Jari Dahmen; Eoghan T Hurley; Yoshiharu Shimozono; Christopher D Murawski; Sjoerd A S Stufkens; Gino M M J Kerkhoffs; John G Kennedy
Journal:  Cartilage       Date:  2021-02-22       Impact factor: 4.634

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.